WebApr 10, 2024 · ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China. ... Asia Bio Partnering Forum 2024. Singapore and Digital. April 26-27, 2024. ChinaBio® News Greg Scott Interviewed at BIO-Europe Spring. WebFeb 6, 2024 · Zhimeng Biopharma Out-Licenses TLR8 Agonist, an HBV Therapy, to GSK Zhimeng Biopharma Out-Licenses TLR8 Agonist, an HBV Therapy, to GSK publication date: Feb 6, 2024 Shanghai Zhimeng Biopharma signed an agreement to out-license global rights for its TLR8 agonist to GlaxoSmithKline as an HBV treatment.
ChinaBio®合作论坛2024 - 参会注册 - ChinaBio® Partnering
WebMar 31, 2024 Shanghai Ablaze Pharma in-licensed China rights to a first-in-class novel peptide drug candidate aimed at treating liver cancer from San Diego’s RayzeBio. The candidate targets GPC3, which is expressed only by the liver. In preclinical tests, the GPC3 candidate showed tumor specific uptake and anti-tumor efficacy in preclinical models. WebApr 6, 2024 · 延續ChinaBio® 合作論壇的成功之路,EBD 集團今年隆重推出全新會議系列,首屆Asia Bio合作論壇將 於2024 年4 月26 - 27 日在新加坡烏節希爾頓酒店舉行。. 本論壇將有效驅動亞洲更大範圍的生命科學市場合作與創新。. Building on the unrivalled success of ChinaBio® Partnering Forum ... fisher kx-100
Conferences > Life Sciences > Biotechnology > United States
WebThe inaugural Asia Bio Partnering Forum builds on the unrivalled success of its sister event ChinaBio® Partnering Forum. The event will take place in-person from April 26–27, … WebMar 6, 2024 · Tuesday, March 21, will host the popular panel discussion "Day in the life of an experienced dealmaker" featuring Kinam Hong, Partner at Sofinnova Partners , Philippe Lopes-Fernandes, Executive... WebOct 31, 2024 · ChinaBio® Partnering Forum 2024 -. 至关注 ChinaBio® 合作论坛的各位朋友,. 近期各地参会者纷纷北京健康码弹窗,无法进京。. 在得到相关政府机构的确认之后,我们遗憾地决定将线下会议以数字形式交 … canadian red cross abbotsford